Sunniva Inc SNNVF

RE:RE:RE:RE:RE:still think this....

[Bluechip2]

just to add if I may, the medical play for Sunniva is going to be more second tier, ie with DIN#, proven research and FDA approved. For example, Epidiolex, when it takes off will need large scale pharmaceutical suppliers of their proprietary concoctions, which is estimated to be $32,000/ patient in sales. The secure white label services will be secured at a premium. Linton is looking to get first approved in Canada for developing an FDA approved sleeping aid, that will require specialized, secure supplies. For now, medical cannabis is an anecdotal remedy for conditions.